Your browser doesn't support javascript.
loading
A single homogeneous assay for simultaneous measurement of bispecific antibody target binding.
Christian, Elizabeth A; Hussmann, G Patrick; Babu, Meghna; Prophet, Meagan; Mazor, Yariv; Chen, Weimin; Grigoriadou, Christina; Lin, Shihua.
Afiliación
  • Christian EA; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. Electronic address: elizabeth.christian@astrazeneca.com.
  • Hussmann GP; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Babu M; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Prophet M; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Mazor Y; Department of Antibody Discovery and Protein Engineering, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Chen W; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Grigoriadou C; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Lin S; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
J Immunol Methods ; 496: 113099, 2021 09.
Article en En | MEDLINE | ID: mdl-34224737

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoensayo / Anticuerpos Biespecíficos / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Especificidad de Anticuerpos / Antígenos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Methods Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoensayo / Anticuerpos Biespecíficos / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Especificidad de Anticuerpos / Antígenos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Methods Año: 2021 Tipo del documento: Article
...